Qube Research & Technologies (QRT)
GRNA

Qube Research & Technologies (QRT)’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-117,414
Closed -$35K – 4418
2023
Q2 		$35K Buy
+117,414
New +$35.4K ﹤0.01% 2109
2021
Q4 		– Sell
-17,857
Closed -$177K – 3110
2021
Q3 		$177K Buy
+17,857
New +$175K ﹤0.01% 1688

Qube Research & Technologies (QRT)'s GRNA Position: Q3 2023 in Review

Qube Research & Technologies (QRT) sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 117,414 shares — an estimated $35K sold.

Qube Research & Technologies (QRT) first reported a position in GRNA in Q3 2021 and held it in 2 quarters. The position peaked at $177K in Q3 2021. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

  • Qube Research & Technologies (QRT) reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 117,414 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $35K.
  • Qube Research & Technologies (QRT) first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q3 2021 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s GreenLight Biosciences Holdings, PBC Common Stock position peaked at $177K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2023, filed 13 Nov 2023.